Last reviewed · How we verify
NCT06181604: SYMON
Multicenter Symphony IL-6 Monitoring Sepsis ICU Study
trial in Sepsis in 143 participants. Completed in 12 July 2024.
12 July 2024
Quick facts
| Lead sponsor | Bluejay Diagnostics, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 143 |
| Start date | 12 January 2024 |
| Primary completion | 12 July 2024 |
| Estimated completion | 12 July 2024 |
| Sites | 7 locations across United States |
Conditions studied
- Sepsis — all drugs for Sepsis →
- Septic Shock — all drugs for Septic Shock →
Sponsor
Bluejay Diagnostics, Inc.
Who can join
22 and older, any sex, with Sepsis or Septic Shock. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to establish an IL-6 concentration cutoff and optimal time point(s) for using Symphony IL-6 that predict 28-day mortality in patients who are admitted or are intended to be admitted to the intensive care unit (ICU) diagnosed with sepsis or septic shock.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06181604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sepsis
Currently open trials in the same condition.
- NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
- NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
Other Bluejay Diagnostics, Inc. trials
Trials by the same sponsor.
- NCT07425587 — Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study · not yet recruiting
- NCT06654895 — Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study · recruiting
- NCT05665153 — Symphony IL-6 Study in Patients at Risk of Severe Sepsis · unknown
- NCT05060250 — Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19 · unknown
- NCT05048927 — Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06181604 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bluejay Diagnostics, Inc.
- Last refreshed: 3 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06181604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing